Cryoablation
A minimally invasive medical technology designed to treat solid tumors
AccuTarget cryoablation, developed by AccuTarget MediPharma (Shanghai) Co., Ltd., is a minimally invasive medical technology designed to treat solid tumors by destroying cancer cells through extreme cold, typically utilizing nitrogen or argon gas. The system is recognized for its ability to create precise, image-guided, and monitored destruction of tumors, often used when surgery is not feasible.
TACTIC® Antarctic™ Cryoablation Equipment
Tartic® Antarctic™ Cryoablation Equipment is derived from the Joule-Thomson effect, which is a high-tech tumor treating device that integrates two medical technologies of “targeted” and “minimally invasive” therapy. It breaks through the limitations of traditional refrigerants, adopting regular nitrogen as a refrigerant, which can inactive tumor cells without damaging normal tissues other than the tumor cells, to stimulate the body’s immunity and improve the efficacy of treatment as a green and minimally invasive treatment.
